Seed Round - ArrePath
Investment Firm
Overview
ArrePath is an anti-infective drug discovery company addressing the global health challenge of drug resistant infections.
Announced Date
Mar 03, 2022
Closed on Date
Mar 04, 2022
Funding Type
Seed
Highlights
Location
United States, North America
Social
Investor Lead
Insight Partners
Insight Partners is a convertible_note and debt and early_stage_venture and late_stage_venture and private_equity and seed firm.
Innospark Ventures
Innospark Ventures is a early_stage_venture and seed and venture firm.
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund is a early_stage_venture and seed firm.
Participant Investors
6
Round Details and Background
ArrePath raised $20000000 on 2022-03-03 in Seed Round
ArrePath is an anti-infective drug discovery company addressing the global health challenge of drug resistant infections.
Company Funding History
1
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Mar 03, 2022 |  Seed Round - ArrePath | 7 | - | 20.0M |
Recent Activity
There is no recent news or activity for this profile.